Conditions: Contraception Female Contraception
Keywords: Pregnancy Prevention Oral Contraceptives
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 2858
Healthy volunteers: yes

Brief summary:
This is an open-label, single treatment study. All subjects will receive 12 months of oral contraceptive therapy with DR-102. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a daily diary.

Detailed description:

Arms:
arm 1: desogestrel/ethinyl estradiol 0.15/0.02 mg for 21 days then ethinyl estradiol 0.01 mg for 7 days

Interventions: intervention 1: DR-102
Intervention descriptions: intervention 1: None

Protocol document: